Scientist, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow
Objective: Nature-inspired synthesis of medicarpin and their derivativities as a novel dual-acting drug candidate for the treatment of osteoporosis: preclinical development. Evaluation of CDRI osteogenic lead medicarpin (water-soluble salt) in skeletal muscle atrophy. Engineered self-assembled composites bearing medicarpinl potential osteogenic agents for spatial drug targeting and bone regeneration.
Accessibility Controls